MBAI
Check-Cap Ltd.NASDAQHEALTHCAREDIAGNOSTICS & RESEARCH
Key Statistics
Market Cap
$11.88M
P/E Ratio
—
EPS
$-2.22
Beta
0.79
52W High
$3.92
52W Low
$0.59
50-Day MA
$1.74
200-Day MA
$1.46
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Check-Cap Ltd.
Check-Cap Ltd., a clinical stage medical diagnostics company, focuses on capsule-based screening technology products. The company is headquartered in Isfiya, Israel.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-3.76M |
| Operating Margin | 0.00% |
| Return on Equity | -130.10% |
| Return on Assets | -20.80% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $0.64 |
| Price-to-Book | 3.52 |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | 0.74 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $7.29M |
| Float | $4.68M |
| % Insiders | 20.05% |
| % Institutions | 0.54% |
Data last updated: 4/8/2026